首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1575783

全球 II 型胶原蛋白市场 - 2024-2031

Global Type II Collagen Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 202 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球II型胶原蛋白市场规模达2.1448亿美元，预计2031年将达到3.0292亿美元，2024-2031年预测期间复合年增长率为4.41%。

随着全球人口老化的成长，人们对关节健康和行动能力问题的认识不断增强。 II 型胶原蛋白以其支持软骨和关节功能的能力而闻名，其需求量正在增加。这一趋势推动了全球 II 型胶原蛋白市场的扩张，尤其是老年消费者和生活方式积极、重视关节健康的个人。

世界卫生组织表示，各国在为卫生和社会系统做好准备以应对人口迅速老化方面面临重大挑战。到2050年，预计80%的老年人将居住在低收入和中等收入国家，人口老化速度正以前所未有的速度加快。

2020年，60岁及以上的人口数量首次超过5岁以下儿童的数量。此外，2015年至2050年间，全球60岁以上人口比例将增加近一倍，从12%增加至22%。这种人口变化需要采取紧急行动，使医疗保健和社会支持系统适应老年人的需求。

市场动态

骨关节炎盛行率上升

随着骨关节炎变得越来越普遍，特别是在老龄化人口中，对有效治疗和关节保健补充剂的需求显着增加。 II 型胶原蛋白以其支持关节健康和减少发炎的作用而闻名，越来越多地被纳入膳食补充剂、功能性食品和药物中，以满足受这种疾病影响的人们日益增长的需求。

例如，根据骨关节炎 (OA) 行动联盟的数据，骨关节炎的盛行率因年龄、性别和种族而异。从年龄来看，43% 的 OA 患者年龄在 65 岁或以上，88% 的患者年龄在 45 岁或以上。膝关节 OA 的年发病率最高发生在 55 岁至 64 岁之间，儘管有症状的膝关节 OA 患者中一半以上年龄在 65 岁以下。虽然 OA 在 45 岁以下的男性中更为常见，但在该年龄之后的女性中也更为常见。就种族而言，78% 的 OA 患者是非西班牙裔白人。

人们对运动营养的兴趣日益浓厚

人们对运动营养日益增长的兴趣预计将显着推动全球 II 型胶原蛋白市场。随着运动员和健身爱好者越来越关注关节健康、恢復和性能增强，II 型胶原蛋白因其在支持关节完整性、减少发炎和促进软骨修復方面的潜在益处而受到关注，从而推动市场成长。

市场对胶原蛋白补充剂的需求不断增长，尤其是从事高强度运动的个人。这些消费者寻求有助于维持关节健康和预防受伤的产品，从而有助于扩大 II 型胶原蛋白在更广泛的运动营养市场中的份额。人们越来越认识到胶原蛋白在改善活动性和灵活性方面的作用，进一步支持了这一趋势，使其成为运动补充剂和功能性食品市场的关键成分。

Bulk 执行长表示，肌力训练的日益普及推动了直接面向消费者(DTC) 的营养品牌取得了破纪录的业绩，2023 年收入猛增30%，达到1.231 亿欧元。纪录的业绩新客户的大量获取是这一增长背后的关键驱动力。 Bulk 去年增加了近 80 万名新客户，销售了超过 900 万种产品，其中透明乳清蛋白成为成长最快的产品线，而价值必需品系列在生活成本危机中表现良好。

肌酸产品在註重肌肉量增强的客户中仍然很受欢迎，而胶原蛋白和镁产品作为恢復解决方案的需求不断增加。儘管通货膨胀导致原料成本上涨，Bulk 令人印象深刻的收入将调整后的 EBITDA 从 2022 年的 260 万欧元增至 930 万欧元，税前利润从上一年的 66,000 欧元增加到 600 万欧元。

素食和道德问题

随着消费者需求转向植物性和零残忍产品，越来越多的市场对动物来源的产品越来越警惕，例如通常源自鸡胸骨或其他动物组织的 II 型胶原蛋白。这种道德立场，加上全球素食人口的不断增加，可能会阻碍 II 型胶原蛋白市场的成长，因为消费者正在寻求替代的、基于植物的关节健康和皮肤护理解决方案。

此外，随着品牌围绕动物福利和永续性展开道德辩论，II 型胶原蛋白市场也可能面临挑战。动物性胶原蛋白的生产方法经常受到环境影响的审查，这可能会进一步抑制永续性和道德采购高度优先的市场的需求，从而限制市场成长。

细分市场分析

全球 II 型胶原蛋白市场根据形式、来源、应用和地区进行细分。

消费者对 II 型胶原蛋白皮肤保健品的需求不断增长

由于消费者对皮肤保健产品的需求不断增长，以及人们越来越认识到胶原蛋白在增强皮肤弹性、水合作用和整体外观方面的作用，化妆品领域在全球 II 型胶原蛋白市场中占有最大份额。随着消费者越来越注重保持年轻容颜，抗衰老产品越来越受欢迎，其中 II 型胶原蛋白成为关键成分。

对抗衰老和嫩肤解决方案不断增长的需求正在推动化妆品市场的发展，而 II 型胶原蛋白已被证实具有功效。化妆品产业不断发展创新产品形式，例如注入胶原蛋白的面膜、乳液和可摄取的美容补充剂。例如，2023 年 1 月 24 日，Geltor 推出 NuColl，进军护髮市场，这是一种透过发酵生产的纯素胶原蛋白。

市场地域占有率

北美关节疾病的盛行率不断增加

预计北美将主导全球 II 型胶原蛋白市场。主要驱动因素是该地区人口迅速老化，这导致骨关节炎等关节疾病的盛行率不断增加。这对关节保健补充剂产生了巨大的需求，其中 II 型胶原蛋白因其支持软骨和改善关节功能的潜力而被广泛使用。

在广泛的营销努力和强大的分销管道的推动下，消费者对胶原蛋白补充剂的益处的认识不断提高，这有助于北美市场的扩张。该地区还受益于高度发展的医疗保健基础设施和强大的膳食补充剂市场，使人们更容易获得胶原蛋白产品。这些趋势，加上对产品创新和新配方的关注，正在帮助北美保持在全球 II 型胶原蛋白市场的领先地位。

市场竞争格局

该市场的主要全球参与者包括 Ashland Inc.、Athos Collagen Private Limited、Chondrex, Inc.、Advanced BioMatrix、Rousselot、Takara Bio Inc.、SouthernBiotech、REPROCELL Inc.、KOKEN CO., LTD。和金博生物製药股份有限公司。

俄乌战争影响分析

持续不断的俄罗斯-乌克兰战争严重影响了全球 II 型胶原蛋白市场，影响了供应链和消费者行为。衝突扰乱了东欧的农业活动和贸易路线，导致该地区主要原料的短缺和价格上涨。供应链的中断导致 II 型胶原蛋白市场製造商的生产成本增加，促使一些公司将这些成本转嫁给消费者。

战争导致了更广泛的经济不稳定，影响了消费者的支出模式和优先事项。在不确定的时期，消费者可能会减少在补充剂上的可自由支配支出，包括 II 型胶原蛋白产品。随着需求波动，这可能会减缓市场成长，特别是在严重依赖受影响国家进口的地区。

按形式

干燥

液体

按来源

牛科

猪

家禽

其他的

按申请

食品和饮料

卫生保健

化妆品

其他的

按地区

北美洲

我们

加拿大

墨西哥

欧洲

德国

英国

法国

义大利

西班牙

欧洲其他地区

南美洲

巴西

阿根廷

南美洲其他地区

亚太

中国

印度

日本

澳洲

亚太其他地区

中东和非洲

主要进展

2023 年 11 月 4 日，总部位于海得拉巴的製药公司 Lee Pharma 获得行销授权，在阿拉伯联合大公国推出其 Bio-Cartilage SmoothWalk 片剂。这一里程碑标誌着该公司取得的重大成就，因为 Bio-Cartilage SmoothWalk 成为第一个在阿联酋获得许可的印度营养保健品。

2022年3月3日，中国领先的维生素和膳食补充品公司汤臣倍健在其Highflex关节健康品牌下推出了新的胶原蛋白产品。该产品含有 Collavant n2，这是一种来自 Bioiberica（巴塞隆纳）的天然（未变性）II 型胶原蛋白成分，经临床证明可以缓解膝盖不适并改善关节功能。

2021 年 4 月 20 日，Lonza 宣布扩大其 UC-II 未变性胶原蛋白成分系列，推出由经过认证的有机胶原蛋白製成并经过非基因改造项目验证的新补充剂。新型 UC-II 未变性 II 型胶原蛋白旨在透过提供消费者友善的每日一次剂量来解决这一问题，为有机关节健康市场的人们提供更方便的选择。

为什么购买报告？

根据形式、来源、应用和地区可视化全球 II 型胶原蛋白市场细分，并了解关键商业资产和参与者。

透过分析趋势和共同开发来识别商业机会。

Excel 电子表格包含 II 型胶原蛋白市场的综合资料集，涵盖所有细分级别。

PDF 报告由详尽的质性访谈和深入研究后的综合分析组成。

产品映射以 Excel 形式提供，包含所有主要参与者的关键产品。

全球 II 型胶原蛋白市场报告将提供约 62 个表格、53 张图表和 202 页。

2024 年目标受众

製造商/买家

产业投资者/投资银行家

研究专业人员

新兴公司

As the aging population grows globally, there is an increasing awareness of joint health and mobility issues. Type II collagen, known for its ability to support cartilage and joint function, is seeing heightened demand. The trend drives global type II collagen market expansion, particularly among elderly consumers and individuals with active lifestyles who prioritize joint health.

According to the World Health Organization, countries face significant challenges in preparing their health and social systems for the rapid demographic shift toward an aging population. By 2050, it is projected that 80% of older adults will reside in low- and middle-income countries and the pace of population aging is accelerating at an unprecedented rate.

In 2020, for the first time, the number of people aged 60 years and older surpassed the number of children under the age of five. Furthermore, between 2015 and 2050, the proportion of the global population over 60 will nearly double, increasing from 12% to 22%. This demographic change requires urgent action to adapt healthcare and social support systems to the needs of older individuals.

Market Dynamics

Rising Prevalence of Osteoarthritis

As osteoarthritis becomes more common, especially among the aging population, the demand for effective treatments and joint health supplements significantly increases. Type II collagen, known for its role in supporting joint health and reducing inflammation, is increasingly being incorporated into dietary supplements, functional foods and pharmaceuticals to address the growing needs of those affected by this condition.

For instance, according to the Osteoarthritis (OA) Action Alliance, the prevalence of OA varies by age, gender and ethnicity. Age-wise, 43% of individuals with OA are 65 or older and 88% are 45 or older. The highest annual incidence of knee OA occurs between the ages of 55 and 64, although more than half of those with symptomatic knee OA are under 65. Gender differences show that 62% of individuals with OA are women. While OA is more common in men under 45, it becomes more prevalent in women after that age. In terms of ethnicity, 78% of those with OA are non-Hispanic whites.

Growing Interest in Sports Nutrition

The growing interest in sports nutrition is expected to drive the global type II collagen market significantly. As athletes and fitness enthusiasts increasingly focus on joint health, recovery and performance enhancement, type II collagen is gaining attention for its potential benefits in supporting joint integrity, reducing inflammation and promoting cartilage repair, driving the market growth.

The market is witnessing a rise in demand for collagen-based supplements, especially from individuals engaged in high-impact sports. These consumers seek products that can help maintain their joint health and prevent injury, contributing to the expansion of the type II collagen segment within the broader sports nutrition market. This trend is further supported by the growing awareness of collagen's role in improving mobility and flexibility, making it a key ingredient in the market for sports supplements and functional foods.

According to Bulk CEO, the rising popularity of strength training has propelled the direct-to-consumer (DTC) nutrition brand to a record-breaking performance, with revenues surging by 30% to EUR 123.1 million in 2023. Strong customer retention and record-high new customer acquisition were key drivers behind this growth. Bulk added nearly 800,000 new customers last year and sold over nine million products, with clear whey protein emerging as the fastest-growing line and the value essentials range performing well amid the cost of living crisis.

Creatine products remained popular among customers focused on muscle mass building, while collagen and magnesium products saw increased demand as recovery solutions. Bulk's impressive revenues boosted adjusted EBITDA to EUR 9.3 million, up from EUR 2.6 million in 2022 and pre-tax profits rose to EUR 6 million, compared to just EUR 66k the previous year, despite inflation-driven ingredient cost hikes.

Vegan and Ethical Concerns

As consumer demand shifts towards plant-based and cruelty-free products, a growing segment of the market is becoming increasingly wary of products derived from animal sources, such as type II collagen, which is typically sourced from chicken sternum or other animal tissues. This ethical stance, combined with the rising vegan population globally, may hinder the growth of the type II collagen market, as consumers seek alternative, plant-based solutions for joint health and skin care.

Moreover, the type II collagen market is also likely to face challenges as brands navigate the ethical debates around animal welfare and sustainability. The production methods for animal-derived collagen are often scrutinized for their environmental impact, which can further dampen demand in markets where sustainability and ethical sourcing are high priorities, restraining market growth.

Market Segment Analysis

The global type II collagen market is segmented based on form, source, application and region.

Rising Consumer Demand for Type II Collagen Skin Health Products

The cosmetics segment holds the largest share of the global type II collagen market due to a combination of rising consumer demand for skin health products and the increasing awareness of collagen's role in enhancing skin elasticity, hydration and overall appearance. As consumers become more focused on maintaining a youthful appearance, there is a surge in the popularity of anti-aging products, with type II collagen becoming a key ingredient.

The growing demand for anti-aging and skin-rejuvenating solutions is driving the cosmetics market forward with type II collagen's proven benefits. The cosmetics industry is continually evolving with innovative product formats such as collagen-infused masks, lotions and ingestible beauty supplements. For instance, on January 24, 2023, Geltor expanded into the hair care market with the launch of NuColl, a vegan collagen produced through fermentation.

Market Geographical Share

Increasing Prevalence of Joint Disorders in North America

North America is expected to dominate the global type II collagen market. The primary driver is the region's rapidly aging population, which is leading to an increasing prevalence of joint disorders such as osteoarthritis. This is creating significant demand for joint health supplements, where type II collagen is widely used for its potential to support cartilage and improve joint function.

Growing consumer awareness about the benefits of collagen supplements, driven by extensive marketing efforts and strong distribution channels, is contributing to market expansion in North America. The region also benefits from a highly developed healthcare infrastructure and a robust dietary supplement market, allowing for easier access to collagen-based products. These trends, along with a focus on product innovation and new formulations, are helping North America maintain its leading position in the global type II collagen market.

Market Competitive Landscape

The major global players in the market include Ashland Inc., Athos Collagen Private Limited, Chondrex, Inc., Advanced BioMatrix, Rousselot, Takara Bio Inc., SouthernBiotech, REPROCELL Inc., KOKEN CO., LTD. and JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED.

Russia-Ukraine War Impact Analysis

The ongoing Russia-Ukraine war has significantly affected the global type II collagen market, influencing supply chains and consumer behavior. The conflict has disrupted agricultural activities and trade routes in Eastern Europe, leading to shortages and increased prices of key ingredients sourced from the region. This disruption in supply chains has resulted in heightened production costs for manufacturers in the type II collagen market, prompting some companies to pass these costs on to consumers.

The war has contributed to broader economic instability, affecting consumer spending patterns and priorities. In times of uncertainty, consumers may reduce discretionary spending on supplements, including type II collagen products. This could slow market growth as demand fluctuates, especially in regions heavily reliant on imports from affected countries.

By Form

Dry

Liquid

By Source

Bovine

Porcine

Poultry

Others

By Application

Food and beverage

Healthcare

Cosmetics

Others

By Region

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

On November 4, 2023, Lee Pharma, a Hyderabad-based pharmaceutical company, received marketing authorization to launch its Bio-Cartilage SmoothWalk tablets in the United Arab Emirates. This milestone marks a significant achievement for the company, as Bio-Cartilage SmoothWalk becomes the first Indian nutraceutical product to be licensed in the UAE.

On March 3, 2022, ByHealth, a leading vitamin and dietary supplements company in China, introduced a new collagen product under its Highflex joint health brand. This product features Collavant n2, a native (undenatured) type II collagen ingredient from Bioiberica (Barcelona), which has been clinically proven to alleviate knee discomfort and improve joint function.

On April 20, 2021, Lonza announced the expansion of its UC-II undenatured collagen ingredient line with the launch of a new supplement made from certified organic collagen and verified by the Non-GMO Project. The new UC-II undenatured type II collagen aims to solve this by offering a consumer-friendly, once-daily dose, providing a more convenient option for those in the organic joint-health market.

Why Purchase the Report?

To visualize the global type II collagen market segmentation based on form, source, application and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel spreadsheet containing a comprehensive dataset of the type-ii-collagen-market, covering all levels of segmentation.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global type II collagen market report would provide approximately 62 tables, 53 figures and 202 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Form
3.2. Snippet by Source
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Osteoarthritis
  - 4.1.1.2. Growing Interest in Sports Nutrition
- 4.1.2. Restraints
  - 4.1.2.1. Vegan and Ethical Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Form

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 6.1.2. Market Attractiveness Index, By Form
6.2. Dry*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Liquid

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Bovine*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Porcine
7.4. Poultry
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Food and beverage*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Healthcare
8.4. Cosmetics
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. US
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Ashland Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Athos Collagen Private Limited
11.3. Chondrex, Inc.
11.4. Advanced BioMatrix
11.5. Rousselot
11.6. Takara Bio Inc.
11.7. SouthernBiotech
11.8. REPROCELL Inc.
11.9. KOKEN CO., LTD.
11.10. JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED (*LIST NOT EXHAUSTIVE)

12. Appendix

12.1. About Us and Services
12.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球 II 型胶原蛋白市场 - 2024-2031

Global Type II Collagen Market - 2024-2031

市场动态

俄乌战争影响分析

按形式

按来源

按申请

按地区

主要进展

为什么购买报告？

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：按形式

第 7 章：按来源

第 8 章：按申请

第 9 章：按地区

第 10 章：竞争格局

第 11 章：公司简介

第 12 章：附录